Unknown NA INTERVENTIONAL 2-arm NCT03597984

Reduction of Pain Symptoms With Stereotactic Radiotherapy on Bone Metastases (PREST)

PREST: Pain REduction With Bone Metastases STereotactic Radiotherapy: A Phase III Randomized Multicentric Trial

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Conditions Bone Metastases Radiotherapy Technology

Interventions Simultaneous Integrated Boost-SIB on macroscopic metastases

Updated 8 times since 2018 Last updated: Jul 1, 2019 Started: Jul 1, 2019 Primary completion: Jul 1, 2019 Completion: Dec 28, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Bone Metastases and Radiotherapy and is currently ongoing. Fondazione Policlinico Universitario Agostino Gemelli IRCCS leads this study, which shows 8 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Oct 2021 — Jul 2024 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status
Jan 2021 — Oct 2021 [monthly]

Not Yet Recruiting NA
Aug 2019 — Jan 2021 [monthly]

Not Yet Recruiting NA

▶ Show 3 earlier versions

Jul 2019 — Aug 2019 [monthly]

Not Yet Recruiting NA
Sep 2018 — Jul 2019 [monthly]

Not Yet Recruiting NA
Aug 2018 — Sep 2018 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Data source: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.